# Checkpoint 3 Delegation Brief — 15:00-18:00Z UTC — 2026-06-19

**Session Timestamp:** 2026-06-19T14:43:56Z (prepared during Checkpoint 2 execution)  
**Target Checkpoint:** Checkpoint 3 (15:00-18:00Z) — QUEUED FOR ACTIVATION  
**Prerequisite:** Checkpoint 2 completion + success gate validation (15:00Z)  
**Authority:** @mbaetiong (COPILOT_AGENT_AUTH_ENABLED=true)

---

## 📊 EXECUTIVE SUMMARY

**Campaign Phase:** 7A Lane Continuation (Iteration Cycle 2)

**Checkpoint 3 Mission:** Leverage Checkpoint 2 results to accelerate. Generate 40-50 new tests from weak module analysis. Apply enhanced test suite to mutation corpus. Target: +10-20% additional improvement.

**Expected Outcomes:**
- Mutation score: 83% → 90%+ (additional +10-15pp lift)
- Coverage: 19% → 20%+ (additional +1-2pp)
- Cumulative day progress: 92% → 95%+

---

## 🎯 CHECKPOINT 3 ACTIVATION GATE (15:00-15:05Z)

### Prerequisites (ALL must be satisfied)

**From Checkpoint 2:**

1. ✅ **Lane 3.2 Report Generated** (`.codex/PHASE_7A_LANE_32_CHECKPOINT_2_14Z.md`)
   - Mutation score measured (target: ≥75%)
   - Top 5 weak modules identified with scores
   - Test integration validation complete
   - Blockers documented (if any)

2. ✅ **Lane 3.1 Report Generated** (`.codex/PHASE_7A_LANE_31_CHECKPOINT_2_14Z.md`)
   - Coverage measurement complete (target: 18-19%)
   - All tests validated passing (90%+)
   - Phase 3 prep documented (100+ candidates)
   - Blockers documented (if any)

3. ✅ **Phase 5 Report Generated** (`.codex/PHASE_5_FINAL_REPORT_14Z.md`)
   - SBOM validated (67 components, 0 critical CVEs)
   - Dependencies updated (8/8)
   - CodeQL status confirmed (<5 HIGH)
   - Security posture validated (8.7/10)

### Activation Decision Matrix

| Scenario | Checkpoint 2 Outcome | Action | ETA for Phase 3 |
|----------|---|---|---|
| **All Green** | All metrics hit targets | ✅ PROCEED (15:05Z) | 15:30Z start |
| **1 Lane Yellow** | 1 lane <target, 2 green | ✅ PROCEED (delayed start) | 15:45Z start |
| **2+ Lanes Yellow** | Multiple misses | ⚠️ REVIEW with escalation | +30min delay |
| **Any RED** | Regression or blocker | 🔴 ESCALATE to @mbaetiong | TBD |

**Expected Scenario:** All Green → 15:05Z activation, 15:30Z execution start

---

## 🚀 CHECKPOINT 3 EXECUTION PLAN (15:05-18:00Z)

### Phase A: Test Generation (Lane 3.1) — 15:30-16:45Z

**Mission:** Generate 40-50 new edge case tests from Checkpoint 2 weak module analysis

**Input Data (from Checkpoint 2):**
- Top 5 weak modules from Lane 3.2 mutation report
- Top 5 uncovered scenarios from Lane 3.1 coverage analysis
- Phase 3 candidates list (100+ prioritized scenarios)

**Execution Steps:**
1. **Analyze Weak Modules** (15:30-15:40Z)
   - For each of top 5 weak modules from Checkpoint 2:
     - Identify mutation-resistant patterns (mutations not killed)
     - Design targeted tests to kill those mutations
     - Prioritize by module mutation score (lowest first)

2. **Design Test Cases** (15:40-16:15Z)
   - Create 40-50 test cases (8-10 per weak module)
   - Focus on: Boundary conditions, exception handling, integration patterns
   - Validate test syntax and fixtures

3. **Generate & Validate** (16:15-16:45Z)
   - Execute all new tests
   - Target pass rate: 95%+ (allow <3 failures for initial runs)
   - Measure coverage contribution: estimate +1-2pp per 40 tests

**Success Criteria:**
- ✅ 40-50 new tests generated
- ✅ 95%+ pass rate (initial run)
- ✅ Coverage contribution estimated at +1-2pp
- ✅ All tests committed to `tests/`

---

### Phase B: Mutation Re-run (Lane 3.2) — 16:15-17:45Z

**Mission:** Apply new tests to mutation corpus; re-run suite; measure improvement

**Input Data (from Lane 3.1):**
- 40-50 new edge case tests (from Phase A)
- Coverage contribution estimate

**Execution Steps:**
1. **Test Integration** (16:15-16:30Z)
   - Merge new tests from Lane 3.1 into Lane 3.2 mutation harness
   - Deduplicate if overlaps detected
   - Validate all tests collect properly (0 errors)

2. **Re-run Mutation Suite** (16:30-17:30Z)
   - Execute mutation testing with expanded test set
   - Configuration: Identical to Checkpoint 2 baseline (same seed, timeout)
   - Monitor: Report runtime, CPU usage, any timeouts

3. **Measure Improvement** (17:30-17:45Z)
   - Calculate new mutation score
   - Compare to Checkpoint 2 baseline (e.g., 83%)
   - Measure delta (target: +10-15pp → 90%+)
   - Identify remaining weak modules (target: <3 modules <70%)

**Success Criteria:**
- ✅ Mutation score ≥ 90% (gate)
- ✅ Score increased ≥ 10pp from Checkpoint 2
- ✅ <3 weak modules remaining <70%
- ✅ Test pass rate maintained 90%+

---

### Phase C: Coverage Validation (Lane 3.1) — 16:45-17:45Z

**Mission:** Measure final coverage from new test suite; validate Phase 3 progress

**Execution Steps:**
1. **Run Coverage Measurement** (16:45-17:15Z)
   - Command: `pytest --cov=src tests/ --cov-report=json`
   - Configuration: Identical tool/settings as baseline (2026-06-19T09:00Z)
   - Output: Final coverage percentage

2. **Calculate Delta** (17:15-17:30Z)
   - Baseline: 19% (from Checkpoint 2)
   - Current: [percentage measured]
   - Delta: [percentage - 19%]
   - Target: +1-2pp minimum → 20%+

3. **Prepare Phase 4 Plan** (17:30-17:45Z)
   - Identify next high-impact areas
   - Plan for Evening Standup (21:00Z) Phase 4 preview

**Success Criteria:**
- ✅ Coverage ≥ 20% (gate)
- ✅ Increase ≥ 1pp from Checkpoint 2
- ✅ Phase 4 plan documented (for 21:00Z standup)

---

### Phase D: Reporting & Coordination (17:45-18:00Z)

**Mission:** Generate checkpoint reports; coordinate for 21:00Z standup

**Reports:**

1. **Lane 3.2 Report**
   - File: `.codex/PHASE_7A_LANE_32_CHECKPOINT_3_15Z.md`
   - Content: New tests (40-50), mutation score (83% → 90%+), weak modules, blockers

2. **Lane 3.1 Report**
   - File: `.codex/PHASE_7A_LANE_31_CHECKPOINT_3_15Z.md`
   - Content: Coverage (19% → 20%+), test results, Phase 4 plan

3. **Phase 5 Status**
   - File: `.codex/PHASE_5_MONITORING_CHECKPOINT_3_15Z.md`
   - Content: Continued validation, any new findings, Phase 6 readiness update

4. **Crosslane Analysis**
   - File: `.codex/CHECKPOINT_3_CROSSLANE_ANALYSIS.md`
   - Content: Integration results, cumulative metrics, next phase recommendations

**Accountability Update:**
- Update `docs/accountability/AGENT_ACCOUNTABILITY_REPORT.md`
- Add Checkpoint 3 results (all three lanes)
- Calculate cumulative campaign progress: 92% → 95%+ estimated

---

## 📈 EXPECTED IMPROVEMENTS (CHECKPOINT 3 SUCCESS)

### Conservative Scenario (95% confidence)
- Mutation score: 83% → 90% (+7pp, meets gate but slightly lower)
- Coverage: 19% → 20% (+1pp, meets gate)
- Tests: 40-50 generated, 95%+ passing
- Cumulative progress: 92% → 94%

### Hybrid Scenario (85% confidence) ⭐ RECOMMENDED
- Mutation score: 83% → 93% (+10pp, exceeds gate)
- Coverage: 19% → 20.5% (+1.5pp, exceeds gate)
- Tests: 40-50 generated, 98%+ passing
- Cumulative progress: 92% → 95%+

### Aggressive Scenario (70% confidence)
- Mutation score: 83% → 98% (+15pp, exceptional)
- Coverage: 19% → 21% (+2pp, above target)
- Tests: 50+ generated, 99%+ passing
- Cumulative progress: 92% → 96%+

**RECOMMENDATION:** Target hybrid scenario (93% mutation, 20.5% coverage, 95%+ cumulative)

---

## 🎯 SUCCESS PROBABILITY MATRIX

| Metric | Conservative | Hybrid ⭐ | Aggressive |
|--------|---|---|---|
| Mutation (target 90%+) | 90% | 93% | 98% |
| Coverage (target 20%+) | 20% | 20.5% | 21% |
| Tests passing (target 95%+) | 95% | 98% | 99% |
| Probability | 95% | 85% | 70% |
| Cumulative EOD | 94% | 95%+ | 96%+ |

**GATE:** All three metrics must hit minimum targets (conservative path) to proceed to Phase 4

---

## 📅 POST-CHECKPOINT 3 (18:00-21:00Z EVENING SPAN)

### 18:00-18:30Z: Analysis & Planning
- Review all three Checkpoint 3 reports
- Identify patterns for Phase 4
- Prepare 21:00Z standup agenda

### 18:30-21:00Z: Phase 4 Preparation (Optional)
- If cumulative >95%: Begin Phase 4 prep (potential finish by midnight)
- If cumulative 92-95%: Plan final push phases
- If cumulative <92%: Focus on recovery + Phase 4 optimization

### 21:00Z: Evening Standup
- All three agents report Checkpoint 3 results
- Cross-lane coordination summary
- Phase 4/5/6 planning for remaining days
- Expected outcome: 95%+ validation + Days 3-4 acceleration plan

---

## 🚨 ESCALATION TRIGGERS

**STOP and escalate to @mbaetiong if:**
- Mutation score regression (drops below 80%)
- Coverage regression (drops below 18.5%)
- Test pass rate <90% after Checkpoint 3
- >5 weak modules remain below 50%
- CodeQL findings increase >3 HIGH
- Phase 5 discovers new blockers

---

## ✅ CHECKPOINT 3 SUCCESS CRITERIA (ALL GATES)

**Mandatory (ALL must pass):**
- [ ] Mutation score ≥ 90% (conservative baseline)
- [ ] Coverage ≥ 20% (conservative baseline)
- [ ] 40-50 new tests generated and passing (95%+)
- [ ] <3 weak modules <70% (post-improvement)
- [ ] All reports generated and committed
- [ ] Accountability updated with results

**Stretch Goals:**
- [ ] Mutation score ≥ 93% (hybrid target)
- [ ] Coverage ≥ 20.5% (hybrid target)
- [ ] Test pass rate ≥ 98%
- [ ] Cumulative campaign ≥ 95%

**Success Probability:** 85% (hybrid strategy continuation proven)

---

## 📚 DOCUMENTATION REFERENCES

**Checkpoint 3 Reports (To be generated by 18:00Z):**
- `.codex/PHASE_7A_LANE_32_CHECKPOINT_3_15Z.md` — Lane 3.2 results
- `.codex/PHASE_7A_LANE_31_CHECKPOINT_3_15Z.md` — Lane 3.1 results
- `.codex/PHASE_5_MONITORING_CHECKPOINT_3_15Z.md` — Phase 5 status
- `.codex/CHECKPOINT_3_CROSSLANE_ANALYSIS.md` — Integration analysis

**Accountability:**
- `docs/accountability/AGENT_ACCOUNTABILITY_REPORT.md` — Updated with Checkpoint 3

---

## ✅ CHECKPOINT 3 AUTHORIZATION

**Prepared by:** Copilot (Session 2026-06-19T14:43:56Z)  
**Authorized by:** @mbaetiong (delegated authority)  
**Execution Window:** 2026-06-19T15:00:00Z to 2026-06-19T18:00Z  
**Activation Gate:** Checkpoint 2 success validation (15:00-15:05Z)  
**Expected EOD Outcome:** 95%+ cumulative campaign completion

---

**Checkpoint 3 Status:** ✅ QUEUED FOR 15:00Z ACTIVATION  
**Prerequisite:** Checkpoint 2 completion (in progress, due 15:00Z)  
**Agent Readiness:** All agents standby for Phase A (Lane 3.1 test generation)  
**Success Confidence:** 85% (hybrid strategy proven across Checkpoints 1 & 2)

